Encompass Health (EHC) Cash from Investing Activities (2009 - 2026)

Encompass Health has reported Cash from Investing Activities for 18 years, with the latest figure at -$150.1 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities rose 5.3% year-over-year to -$150.1 million; the trailing twelve-month figure through Mar 2026 stood at -$756.2 million (down 10.86% YoY), and the FY2025 full-year result was -$764.6 million, down 17.04% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at -$150.1 million, up from -$239.4 million in the prior quarter.
• The five-year high for Cash from Investing Activities was -$104.0 million in Q1 2023, with the low at -$239.4 million in Q4 2025.
• Historically, Cash from Investing Activities has averaged -$164.6 million across 5 years, with a median of -$161.5 million in 2024.
• The largest YoY upside for Cash from Investing Activities was 45.49% in 2022 against a maximum downside of 40.56% in 2022.
• Encompass Health's Cash from Investing Activities stood at -$206.4 million in 2022, then slipped by 0.82% to -$208.1 million in 2023, then climbed by 2.11% to -$203.7 million in 2024, then retreated by 17.53% to -$239.4 million in 2025, then jumped by 37.3% to -$150.1 million in 2026.
• The last three Cash from Investing Activities figures came in at -$150.1 million (Q1 2026), -$239.4 million (Q4 2025), and -$201.3 million (Q3 2025), per Business Quant data.